Platform
Vaccines
End-to-end vaccine innovation, manufacturing readiness, and rapid response capabilities.
Saudi Biotechnology Platform
Building Saudi Arabia’s Next Global Biotechnology Champion
BioTUWAIQ is building Saudi Arabia’s next-generation biotechnology platform through strategic technology acquisition, localization, scientific innovation, advanced manufacturing, and global partnerships.
2030+
Vision alignment and national biotech strategy
Global
Partnerships with pharma, biotech, and academia
Secure
Health security and advanced manufacturing focus
Platform Pillars
Technology transfer • Localization • Scale manufacturing
About BioTUWAIQ
Building Saudi Arabia’s next global biotechnology champion
BioTUWAIQ is an institutional biotechnology platform established to bridge global innovation with Saudi Arabia’s National Biotechnology Strategy and Vision 2030. We advance a national-scale model that acquires, localizes, develops, and commercializes world-class biotechnology platforms while strengthening health security, scientific excellence, technology transfer, and economic diversification.
We build biotechnology platforms—not single products.
Strategic Localization
Transfer globally proven platforms into Saudi Arabia with integrated manufacturing, regulatory, and clinical pathways.
National Health Security
Advance biosecurity, pandemic preparedness, and resilient supply chains aligned with national priorities.
Scientific Excellence
Build world-class research capabilities with global partnerships, talent development, and translational science.
Economic Diversification
Deliver sovereign biotechnology assets that expand advanced manufacturing and investment returns.
Platform Strategy
Vision 2030
Strategic Focus Areas
Priority platforms shaping national biotechnology leadership
BioTUWAIQ advances a balanced portfolio spanning health security, advanced therapeutics, and platform technologies to accelerate national impact and global competitiveness.
Therapeutics
Cell & Gene Therapy
Localized advanced therapies with robust clinical translation and commercialization pathways.
Oncology
Cancer Immunotherapy
Next-generation immune-oncology platforms and clinical partnerships for durable outcomes.
Precision
Personalized Medicine
Data-driven precision therapeutics aligned to population health and genomic insights.
Security
Biosecurity & Pandemic Preparedness
Integrated readiness programs for national resilience and rapid outbreak containment.
Defense
Counter-Bioterrorism Technologies
Strategic safeguards, diagnostics, and response platforms protecting national health.
Health
Drug Abuse Biotechnology Solutions
Biotechnology-led prevention, treatment, and monitoring tools for public health.
Platforms
Advanced Viral Vector Platforms
Scalable vector design, manufacturing, and quality systems for advanced therapies.
Platform Strategy
A national-scale biotechnology platform engineered for global competitiveness.
BioTUWAIQ orchestrates the full technology journey—from acquisition to commercialization—through a coordinated platform that aligns scientific rigor, national priorities, and investor-grade execution. Each pillar operates as a modular engine, creating an integrated ecosystem for sustained biotech leadership.
Platform Outcomes
- Accelerates strategic asset acquisition and technology transfer.
- Builds sovereign manufacturing and advanced clinical capability.
- Enables global partnerships with measurable commercial impact.
Technology Acquisition
Targeted acquisition of high-impact platforms, assets, and capabilities aligned with national biotechnology priorities.
Technology Localization
Structured transfer and localization to secure sovereign control of critical biotech value chains.
Intellectual Property
Strategic IP development, protection, and portfolio management to expand global competitiveness.
Scientific Research
Deep scientific programs focused on translational discoveries with national and global relevance.
Clinical Development
Integrated trial design, regulatory alignment, and clinical execution to de-risk innovation.
Manufacturing
Advanced biomanufacturing infrastructure to deliver secure, scalable, and compliant production.
Global Partnerships
Long-term alliances with global innovators, universities, and strategic institutions.
Commercialization
Market access, scaling, and value capture to position Saudi biotechnology on the global stage.
Strategic Impact
Outcomes that elevate Saudi biotechnology on the global stage
BioTUWAIQ delivers measurable value through three interlocking dimensions of impact, aligned to Vision 2030, national health security, and world-class scientific leadership.
Economic
Catalyzing sustainable growth
- Knowledge Economy
- Advanced Manufacturing
- Foreign Direct Investment
- High-Value Employment
Scientific
Advancing research excellence
- Technology Transfer
- Research Excellence
- International Collaboration
- Talent Development
National
Securing national resilience
- Health Security
- Biotechnology Sovereignty
- Pandemic Preparedness
- Innovation Leadership
National Alignment
Vision 2030 is embedded in our operating model
BioTUWAIQ serves as a public-private platform that accelerates national biotechnology priorities, integrating policy, science, and industrial execution to build a globally competitive Saudi biotech champion.
01
Saudi Vision 2030
Anchoring biotechnology as a pillar of economic diversification, health security, and sovereign innovation with measurable national outcomes.
02
National Biotechnology Strategy
Translating national biotech priorities into investable programs across advanced therapies, bio-manufacturing, and technology transfer.
03
Health Sector Transformation Program
Strengthening national health resilience through localized production of critical biologics, vaccines, and platform technologies.
04
Research, Development & Innovation Strategy
Accelerating translational science with global research partnerships, IP generation, and commercialization pathways.
05
Industrial Localization
Building Saudi manufacturing capability across biologics, viral vectors, and next-generation modalities with global quality standards.
Leadership
Executive stewardship guiding Saudi Arabia’s biotechnology ascent
BioTUWAIQ is led by proven innovators who combine scientific rigor with national strategy, delivering a trusted platform for biotechnology localization, investment, and global partnership.
Institutional leadership mandate
Establish a globally competitive biotechnology institution that advances health security, technology transfer, and economic diversification aligned with Vision 2030.
Founder & CEO
Dr. Ibrahim Alfayyadh
Biotechnology Strategist & Entrepreneur
Biotechnology strategist and entrepreneur specializing in biotechnology localization, strategic investments, healthcare innovation, and international partnerships; leads BioTUWAIQ’s vision of building a globally competitive biotechnology platform that advances scientific excellence, health security, and economic diversification.
Co-Founder & Director
Dr. Abdalraheem Marwan Alshobaki
Government Affairs & Corporate Affairs
Consultant Physician with extensive clinical experience and a strong interest in biotechnology and healthcare innovation; leads government relations, corporate establishment, regulatory coordination, and legal and administrative affairs, supporting BioTUWAIQ’s institutional development and strategic partnerships.
Partnership Invitation
Build Saudi Arabia’s next global biotechnology champion—together.
BioTUWAIQ invites strategic partners to co-develop platforms, transfer advanced technologies, and scale manufacturing capacity aligned with national health security and Vision 2030. We create structured pathways from acquisition and translational research through clinical development, advanced manufacturing, and global commercialization.
Preferred partner types
We engage with institutional partners who can accelerate clinical, scientific, and economic impact.
Strategic collaboration themes
Technology transfer • Co-development & licensing • Advanced biomanufacturing • Capital partnership • National impact programs